Friday, June 10, 2022

< + > Baby Formula Blues: The Latest Regulatory Fiasco Reveals Problems Bigger Than The Recall Itself

As it is, infant formula is very difficult to manufacture and to keep compliant with FDA standards. The industry recognized the implications of the shutdown of the Abbott Nutrition plant and yet the FDA and the White House failed to connect on the issue.

No comments:

Post a Comment

< + > Bonus Features – March 29, 2026 – 57% of execs say AI-based clinical tools are their top tech initiative, 57% of patients say AI isn’t mature enough for docs to trust it, plus 32 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...